MONDAY, April 21, 2025 (HealthDay News) -- For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone plus azithromycin ...

Out-of-pocket cost: This is the amount you pay for care when Medicare doesn’t pay the full cost or offer coverage ... such as azithromycin. With Original Medicare (Part A and Part B), you ...

Azithromycin resistance (≥1 mg/L ... Surveillance Programme "recommended an increased dose of 500 mg [ceftriaxone] to ensure coverage against isolates with high MICs. Coadministration of ...

Included veterans had pneumonia in the VA MidSouth Healthcare Network (January 2007 to 2015) and were given either ceftriaxone + azithromycin ... expanded antimicrobial coverage during the index ...

Ceftriaxone and azithromycin are each used to combat numerous ... is independent journalist specializing in science and LGBTQ coverage. He contributes to NBC News, The New York Times, The Guardian ...

Five of the samples also showed increased resistance to ceftriaxone, the antibiotic given alongside azithromycin in the dual regimen recommended by the CDC. This is the first cluster of cases to ...

was an attempt at preserving the efficacy of ceftriaxone “for as long as possible and until new antimicrobials are available.” Previous studies have shown an association between azithromycin ...

If treatment with ceftriaxone does not work, a doctor may repeat the treatment or consider treatment with other antibiotic drugs, such as gentamicin and azithromycin. Doctors should follow their ...

Neither treatment group had bacterial persistence of urogenital Neisseria gonorrhoeae at test-of-cure. HealthDay News — For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits ...